Boehringer invests $50M in Puerto Rico facilityNovember 25, 2019Boehringer Ingelheim has expanded the production capacity of its manufacturing site in Barceloneta, P.R., with a $50-million investment.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started